Skip to main
MTD

Mettler-Toledo (MTD) Stock Forecast & Price Target

Mettler-Toledo (MTD) Analyst Ratings

Based on 14 analyst ratings
Hold
Strong Buy 21%
Buy 14%
Hold 57%
Sell 0%
Strong Sell 7%

Bulls say

Mettler-Toledo Intl is a global leader in manufacturing and supplying precision instruments and services to customers in the life sciences, industrial, and food retail industries. Its diversified business model enables it to capture demand from multiple end markets. While the company has under-performed compared to its peers in the past, we believe its exposure to non-biomedical research industries and growing demand in China position it for a potential upside in its organic sales growth. However, headwinds such as pressured capex in the food retail industry and potential risks in China could hinder its growth. Overall, we remain positive on Mettler-Toledo Intl's potential growth and see it as a solid investment opportunity.

Bears say

Mettler-Toledo Intl is not immune to the structural headwinds in the packaged food industry, which accounts for a significant portion of its sales, as changes in consumer preferences continue to impact the industry. While the company stands to benefit from the pharma manufacturing reshoring trend, the potential growth from this may be limited compared to its peers. Furthermore, the company's exposure to the Chinese market, which has been volatile and cyclical in recent years, could hinder its organic growth and could lead to a lower valuation multiple. The company's AI/data center exposure through its water purification business may provide some incremental opportunities, but it is not a major driver of growth at this stage. Environmental sustainability and responsible supply chain practices are also potential concerns for the company. While Mettler-Toledo's strong free cash flow could support accretive M&A activity that could accelerate its growth, historic discipline in this area may limit transformative opportunities. The short-term performance of the company's stock may be impacted by softer recent financial results and skepticism about its future growth potential, particularly in comparison to other companies in the life sciences market.

Mettler-Toledo (MTD) has been analyzed by 14 analysts, with a consensus rating of Hold. 21% of analysts recommend a Strong Buy, 14% recommend Buy, 57% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Mettler-Toledo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Mettler-Toledo (MTD) Forecast

Analysts have given Mettler-Toledo (MTD) a Hold based on their latest research and market trends.

According to 14 analysts, Mettler-Toledo (MTD) has a Hold consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $1,438.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $1,438.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Mettler-Toledo (MTD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.